Literature DB >> 2070325

Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix.

M P Hopkins1, G W Morley.   

Abstract

Three hundred forty-five patients with Stage IB squamous cell carcinoma of the cervix were treated at the University of Michigan Medical Center from 1970 to 1985. The overall cumulative 5-year survival rate was 89% and the mean age was 44.6 years. In 213 patients undergoing radical hysterectomy the cumulative 5-year survival rate was 92%; 14 patients were explored for radical hysterectomy that was not performed due to high risk features and their survival rate was 50%. Ninety-seven patients underwent radiation therapy as initial treatment and had a 5-year survival rate of 86%. There was no significant difference when radiation therapy was compared with radical hysterectomy (P = 0.098). The survival rates for lesions 3 cm or smaller were 94% for radical hysterectomy and 88% for radiation therapy. When the lesion was larger than 3 cm, the survival rates were 82% with radical surgery and 73% with radiation therapy. Metastatic disease to lymph nodes was present in 26 of the 213 patients undergoing radical hysterectomy. When 1 to 3 nodes were involved 16 of 19 patients survived and when 4 to 10 nodes were involved 3 of 7 patients survived. The addition of radiation therapy did not influence survival. Complications were similar in both treatment groups. Fistulas occurred in 4 of 213 patients undergoing radical hysterectomy and 1 of 111 undergoing radiation. Second surgery for a complication was required in 6 of 213 patients undergoing radical hysterectomy and 7 of 111 undergoing radiation. Survival and complication rates in early stage squamous cell carcinoma of the cervix are equal with either radical surgery or radiation therapy.

Entities:  

Mesh:

Year:  1991        PMID: 2070325     DOI: 10.1002/1097-0142(19910715)68:2<272::aid-cncr2820680210>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  The twenty-first century role of Piver-Rutledge type III radical hysterectomy and FIGO stage IA, IB1, and IB2 cervical cancer in the era of robotic surgery: a personal perspective.

Authors:  M Steven Piver; Ali Ghomi
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

2.  Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer.

Authors:  F Heinzelmann; G Henke; M von Grafenstein; N Weidner; F Paulsen; A Staebler; S Brucker; M Bamberg; M Weinmann
Journal:  Strahlenther Onkol       Date:  2012-05-23       Impact factor: 3.621

3.  Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.

Authors:  Juan Wang; Tao Wang; Yun-Yi Yang; Yan-Lan Chai; Fan Shi; Z I Liu
Journal:  Mol Clin Oncol       Date:  2014-11-24

4.  Debulking metastatic pelvic nodes before radiotherapy in cervical cancer patients: a long-term follow-up result.

Authors:  Tak-Hong Cheung; Keith Wing-Kit Lo; So-Fan Yim; Sau-Han Yau; May Mei-Yung Yu; Wing-Kay Yeung
Journal:  Int J Clin Oncol       Date:  2011-03-25       Impact factor: 3.402

5.  The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes.

Authors:  Heidi J Gray; Erin Seifert; Victor G Sal Y Rosas; Katrina F Nicandri; Wui-Jin Koh; Barbara A Goff
Journal:  Obstet Gynecol Int       Date:  2010-04-28

6.  Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital.

Authors:  W W Thoms; E R Unger; R Carisio; R Nisenbaum; C O Spann; I R Horowitz; W C Reeves
Journal:  J Natl Med Assoc       Date:  1998-05       Impact factor: 1.798

7.  Experience in stage IB2 cervical cancer and review of treatment.

Authors:  Taner Turan; Burcu Aykan Yıldırım; Gökhan Tulunay; Nurettin Boran; Ferah Yıldız; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-03-01

8.  Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.

Authors:  Oliver Zivanovic; Kaled M Alektiar; Yukio Sonoda; Qin Zhou; Alexia Iasonos; William P Tew; John P Diaz; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2008-09-06       Impact factor: 5.482

Review 9.  Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.

Authors:  Vivek Nama; Georgios Angelopoulos; Jeremy Twigg; John B Murdoch; Jo Bailey; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2018-10-12

10.  Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: importance of positive or close parametrial resection margin.

Authors:  Yi-Jun Kim; Kyung-Ja Lee; Kyung Ran Park; Jiyoung Kim; Wonguen Jung; Rena Lee; Seung Cheol Kim; Hye Sung Moon; Woong Ju; Yun Hwan Kim; Jihae Lee
Journal:  Radiat Oncol J       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.